Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
October 2015: crucial week in Geneva
10/12/2015. Peter Maurer, president of the International Committee of the Red Cross, expressed concern about the politicization of humanitarian aid which paralyzes assistance efforts.
Speech of H.M.E.H. the Prince and Grand Master Fra’ Matthew Festing to the Diplomatic Corps accredited to the Sovereign Order of Malta
01/12/2016. The Grand Master Fra’ Matthew Festing received the Diplomatic Corps accredited to the Sovereign Order of Malta for the traditional audience of the beginning of the new year.
Saving lives and staying alive
03/31/2016. MSF’s reflections on the phenomenon will be required reading
